Results of the 2003–2004 TB Drug Resistance Survey in Romania I. P. Stoicescu, D. Chiotan, O. Moldovan, D. Homorodean, C. Popa, D. Diculencu, A. Macri, I. Husar, L. Ditiu, M. Abdel Aziz, S. Hoffner (Bucharest, Cluj Napoca, Iasi, Romania; Geneva, Switzerland; Stockholm, Sweden)
Source: Annual Congress 2006 - Epidemiological aspects of lung tumors and infections including tuberculosis
Disease area: Respiratory infectionsRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. P. Stoicescu, D. Chiotan, O. Moldovan, D. Homorodean, C. Popa, D. Diculencu, A. Macri, I. Husar, L. Ditiu, M. Abdel Aziz, S. Hoffner (Bucharest, Cluj Napoca, Iasi, Romania; Geneva, Switzerland; Stockholm, Sweden). Results of the 2003–2004 TB Drug Resistance Survey in Romania. Eur Respir J 2006; 28: Suppl. 50, 2650
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The Efficacy of Screening for Tuberculosis Infection in Paediatric Population in the Republic of Tatarstan Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018
TB Portals Program in Ukraine Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
Supervision/monitoring system under the National TB Control Program in Romania Source: Eur Respir J 2005; 26: Suppl. 49, 190s Year: 2005
Cost-Effectiveness of Tuberculosis Screening for Migrant Children in Low-Incidence countries Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018
Nature, Magnitude and Risk Factors of Adverse Drug Reactions in Multidrug Resistant TB Patients in Eritrea Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018
Socioeconomic Conditions Contributing to Multi Drug Resistant (MDR) and Extremely Drug Resistant(XDR) Tuberculosis Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017
Drug-resistant tuberculosis in Turkmenistan: Results of the first nationwide survey Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Observed smoking in car: Results of a study from the National Health Prevention Service of Veneto, northern Italy Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies Year: 2010
Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012 Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014
Treatment Results of Multidrug Resistant Tuberculosis (MDR-TB) Patients in the Aegean Region Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
Tuberculosis in children of Belarus Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Drug resistance in Bulgaria Source: Eur Respir J 2001; 18: Suppl. 33, 471s Year: 2001
Drug resistant tuberculosis in urban hotspot Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014
Clinical Features Associated with Linezolid Resistance Among Multidrug Resistant Tuberculosis Patients at a Tertiary Care Hospital in Mumbai, India Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Clinical Characteristics and Treatment Outcome of Multidrug-Resistant Tuberculosis (MDR-TB) in a Tertiary Centre in Malaysia: A Two-year Experience Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Attitudes And Knowledge Regarding Tuberculosis In High School Students, A Cross Sectional Survey In Northwest Peru Source: International Congress 2017 – Pulmonary infection and inflammation Year: 2017
Drug resistant tuberculosis in Belarus Source: Eur Respir J 2003; 22: Suppl. 45, 519s Year: 2003
Nationwide anti-tuberculosis drug resistance survey in the Republic of Azerbaijan Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes Source: Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018 Year: 2018
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Source: Eur Respir J 2012; 39: 619-625 Year: 2012